Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: Secondary analyses from a NIDA Clinical Trials Network study

Amit Chakrabarti, George E. Woody, Margaret L. Griffin, Geetha Subramaniam, Roger D. Weiss

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: Secondary analyses from a NIDA Clinical Trials Network study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds